The miRNA pathway in neurological and skeletal muscle disease: implications for pathogenesis and therapy. (Q37900519)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751030%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

review article

1 reference

title

The miRNA pathway in neurological and skeletal muscle disease: implications for pathogenesis and therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751030%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

0 references

Christopher R Sibley

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751030%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

25 August 2017

Matthew J A Wood

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751030%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

25 August 2017

publication date

13 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751030%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Medicine

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751030%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751030%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751030%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

1065-1077

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751030%20AND%20SRC:MED&resulttype=core&format=json

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

MicroRNAs in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Identification of mammalian microRNA host genes and transcription units

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Genomic analysis of human microRNA transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

SMAD proteins control DROSHA-mediated microRNA maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Structural requirements for pre-microRNA binding and nuclear export by Exportin 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Nuclear export of microRNA precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Role for a bidentate ribonuclease in the initiation step of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Purified Argonaute2 and an siRNA form recombinant human RISC

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

In vitro reconstitution of the human RISC-loading complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Identification of novel argonaute-associated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Functional siRNAs and miRNAs Exhibit Strand Bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Uncoupling of RNAi from active translation in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

MicroRNA silencing through RISC recruitment of eIF6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Short RNAs repress translation after initiation in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

MicroRNAs direct rapid deadenylation of mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Regulation of miRNA expression during neural cell specification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

A brain-specific microRNA regulates dendritic spine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

MicroRNA regulation of Alzheimer's Amyloid precursor protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

A MicroRNA feedback circuit in midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Dysregulation of miRNA 181b in the temporal cortex in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Schizophrenia is associated with an increase in cortical microRNA biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Heterogeneous dysregulation of microRNAs across the autism spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Regional and cellular gene expression changes in human Huntington's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Sequence variants in SLITRK1 are associated with Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Effects of gender on nigral gene expression and parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Measuring microRNA expression in size-limited FACS-sorted and microdissected samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Skeletal muscle satellite cells and adult myogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Myogenic factors that regulate expression of muscle-specific microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Growth and differentiation of C2 myogenic cells are dependent on serum response factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Muscle-specific microRNA miR-206 promotes muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

MIR-206 regulates connexin43 expression during skeletal muscle development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Distinctive patterns of microRNA expression in primary muscular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

miR-155 gene: a typical multifunctional microRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Laser microdissection-based expression analysis of key genes involved in muscle regeneration in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

siRNAs can function as miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

The Promise of MicroRNA Replacement Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Lentivirus-mediated antagomir expression for specific inhibition of miRNA function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Specificity, duplex degradation and subcellular localization of antagomirs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Improved targeting of miRNA with antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

LNA-mediated microRNA silencing in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Efficient inhibition of miR-155 function in vivo by peptide nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Optimization of peptide nucleic acid antisense oligonucleotides for local and systemic dystrophin splice correction in the mdx mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Novel RNA-based strategies for therapeutic gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Transvascular delivery of small interfering RNA to the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Nanotechnology approach for drug addiction therapy: gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Myotonic dystrophy type 2 and related myotonic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Atelocollagen-based gene transfer in cells allows high-throughput screening of gene functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

MicroRNA Inhibition of Translation Initiation in Vitro by Targeting the Cap-Binding Complex eIF4F

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0781-Z

Identification of blood microRNAs associated to Parkinsonĭs disease

21 January 2018

1 reference

12 December 2020

Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis

1 reference

12 December 2020

PNA-peptide conjugates as intracellular gene control agents

1 reference

12 December 2020

Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins

1 reference

12 December 2020

Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways

1 reference

12 December 2020

MicroRNAs and cardiac pathology

1 reference

12 December 2020

Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer

1 reference

12 December 2020

MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study

1 reference

12 December 2020

10.1007/S00109-011-0781-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751030%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21751030%20AND%20SRC:MED&resulttype=core&format=json